goetzpartners acted as Commercial Due Diligence advisor on the sale of 7days by Silverfleet Capital to Chequers Capital and Paragon Partners
goetzpartners' Private Equity Consulting team supported 7days management and Silverfleet Capital with a Commercial Vendor Due Diligence on the sale of 7days, a leading supplier of modern and innovative medical workwear for the healthcare industry.
The Commercial Vendor Due Diligence comprised a detailed market assessment for the company’s current as well as potential future addressable markets, including an analysis of local market structures and conditions as well as potential go-to-market strategies for further international expansion. The sustainability of the COVID-19 effect was assessed in detail, including a collection of customers' satisfaction levels with 7days through net promoter scores. The company's business model was assessed, including a thorough analysis of its competitive positioning. Conclusively, the results were used to validate the management's business plan and evaluate further strategic growth opportunities.
Founded in 1999 in Lotte, Germany, 7days provides a wide range of high-quality products to more than 300,000 medical professional customers across 12 countries, including Germany, Austria, Switzerland, France, Belgium, the Netherlands and Scandinavia. With its fully integrated multi-channel sales platform, 7days has experienced stable and anti-cyclical growth, both domestically and internationally. 7days has proved not only to be resilient during the current COVID-19 pandemic, but also to successfully enter and grow in new markets, whilst implementing internationally recognised ethical supplier and production standards.
ABOUT SILVERFLEET CAPITAL
Silverfleet Capital is a leading Pan-European private equity firm. The investment teams located in Munich, London, Paris, Stockholm and Amsterdam built a track record across more than 120 deals, with €3.7bn of investments and €6.4bn of proceeds since 1990. This local footprint makes Silverfleet one of the few truly “local” yet integrated, pan-European, mid-market investors, able to support management teams in both their local markets and internationally.
Dr. Sigurd Kitzer